Unknown

Dataset Information

0

Manipulation of Panx1 Activity Increases the Engraftment of Transplanted Lacrimal Gland Epithelial Progenitor Cells.


ABSTRACT: Purpose:Sjögren's syndrome is a systemic chronic autoimmune inflammatory disease that primarily targets the salivary and lacrimal glands (LGs). Currently there is no cure; therefore, cell-based regenerative therapy may be a viable option. LG inflammation is facilitated by extracellular ATP and mediated by the Pannexin-1 (Panx1) membrane channel glycoprotein. We propose that suppression of inflammation through manipulation of Panx1 activity can stimulate epithelial cell progenitor (EPCP) engraftment. Methods:The expression of pannexins in the mouse and human LG was assayed by qRT-PCR and immunostaining. Acute LG inflammation was induced by interleukin-1? (IL1?) injection. Prior to EPCP transplantation, IL1?-injured or chronically inflamed LGs of thrombospondin-1-null mice (TSP-1-/-) were treated with the Panx1-specific blocking peptide (10panx) or the self-deliverable RNAi (sdRNAi). The efficacy of cell engraftment and the area of inflammation were analyzed by microscopy. Results:Panx1 and Panx2 were detected in the mouse and human LGs. Panx1 and proinflammatory factors were upregulated during acute inflammation at days 1 to 3 after the IL1? injection. The analysis of EPCP engraftment demonstrated a significant and reproducible positive correlation between the 10panx peptide or Panx1 sdRNAi treatment and the number of engrafted cells. Similarly, treatment of the LG of the TSP-1-/- mouse (mouse model of chronic LG inflammation) by either Panx1 or Caspase-4 (also known as Casp11) sdRNAi showed a significant decrease in expression of proinflammatory markers and the lymphocyte infiltration. Conclusions:Our results suggest that blocking Panx1 and/or Casp4 activities is a beneficial strategy to enhance donor cell engraftment and LG regeneration through the reduction of inflammation.

SUBMITTER: Basova LV 

PROVIDER: S-EPMC5678547 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Manipulation of Panx1 Activity Increases the Engraftment of Transplanted Lacrimal Gland Epithelial Progenitor Cells.

Basova Liana V LV   Tang Xin X   Umasume Takeshi T   Gromova Anastasia A   Zyrianova Tatiana T   Shmushkovich Taisia T   Wolfson Alexey A   Hawley Dillon D   Zoukhri Driss D   Shestopalov Valery I VI   Makarenkova Helen P HP  

Investigative ophthalmology & visual science 20171101 13


<h4>Purpose</h4>Sjögren's syndrome is a systemic chronic autoimmune inflammatory disease that primarily targets the salivary and lacrimal glands (LGs). Currently there is no cure; therefore, cell-based regenerative therapy may be a viable option. LG inflammation is facilitated by extracellular ATP and mediated by the Pannexin-1 (Panx1) membrane channel glycoprotein. We propose that suppression of inflammation through manipulation of Panx1 activity can stimulate epithelial cell progenitor (EPCP)  ...[more]

Similar Datasets

| S-EPMC7303985 | biostudies-literature
| S-EPMC5442743 | biostudies-literature
| S-EPMC4699416 | biostudies-literature
| S-EPMC5360089 | biostudies-literature
| S-EPMC5536870 | biostudies-literature
| S-EPMC5231359 | biostudies-literature
| S-EPMC3154548 | biostudies-literature
| S-EPMC6951017 | biostudies-literature
| S-EPMC3292353 | biostudies-literature
| S-EPMC5627580 | biostudies-literature